Clinical significance of plasma N-terminal pro- B-type natriuretic peptide in respiratory distress syndrome of the preterm neonate.
Autor(a) principal: | |
---|---|
Data de Publicação: | 2009 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1707 |
Resumo: | Plasma brain-type natriuretic peptide (BNP) is secreted by cardiac myocytes in response to pressure or volume overload. Recently, an assay to measure the N-terminal segment of the pro-hormone (NT-pro-BNP) was developed.(1) To determine the plasma levels of NT-pro-BNP in premature neonates without congenital heart disease; (2) to determine the relationship between the severity of respiratory distress syndrome (RDS) and plasma levels of NT-pro-BNP.Plasma levels of NT-pro-BNP were measured in premature neonates ( |
id |
RCAP_522bc075ef3cc74c605b091fafb1ba83 |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/1707 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Clinical significance of plasma N-terminal pro- B-type natriuretic peptide in respiratory distress syndrome of the preterm neonate.Significado clínico do segmento N-terminal do pró peptídeo natriurético tipo B plasmático na doença das membranas hialinas do recém-nascido de pré-termo.Plasma brain-type natriuretic peptide (BNP) is secreted by cardiac myocytes in response to pressure or volume overload. Recently, an assay to measure the N-terminal segment of the pro-hormone (NT-pro-BNP) was developed.(1) To determine the plasma levels of NT-pro-BNP in premature neonates without congenital heart disease; (2) to determine the relationship between the severity of respiratory distress syndrome (RDS) and plasma levels of NT-pro-BNP.Plasma levels of NT-pro-BNP were measured in premature neonates (Plasma brain-type natriuretic peptide (BNP) is secreted by cardiac myocytes in response to pressure or volume overload. Recently, an assay to measure the N-terminal segment of the pro-hormone (NT-pro-BNP) was developed.(1) To determine the plasma levels of NT-pro-BNP in premature neonates without congenital heart disease; (2) to determine the relationship between the severity of respiratory distress syndrome (RDS) and plasma levels of NT-pro-BNP.Plasma levels of NT-pro-BNP were measured in premature neonates (Ordem dos Médicos2009-08-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1707oai:ojs.www.actamedicaportuguesa.com:article/1707Acta Médica Portuguesa; Vol. 22 No. 4 (2009): Julho-Agosto; 349-54Acta Médica Portuguesa; Vol. 22 N.º 4 (2009): Julho-Agosto; 349-541646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1707https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1707/1286Rocha, GustavoClemente, FátimaRodrigues, TeresaGuimarães, Hercíliainfo:eu-repo/semantics/openAccess2022-12-20T10:58:37Zoai:ojs.www.actamedicaportuguesa.com:article/1707Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:17:19.906847Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Clinical significance of plasma N-terminal pro- B-type natriuretic peptide in respiratory distress syndrome of the preterm neonate. Significado clínico do segmento N-terminal do pró peptídeo natriurético tipo B plasmático na doença das membranas hialinas do recém-nascido de pré-termo. |
title |
Clinical significance of plasma N-terminal pro- B-type natriuretic peptide in respiratory distress syndrome of the preterm neonate. |
spellingShingle |
Clinical significance of plasma N-terminal pro- B-type natriuretic peptide in respiratory distress syndrome of the preterm neonate. Rocha, Gustavo |
title_short |
Clinical significance of plasma N-terminal pro- B-type natriuretic peptide in respiratory distress syndrome of the preterm neonate. |
title_full |
Clinical significance of plasma N-terminal pro- B-type natriuretic peptide in respiratory distress syndrome of the preterm neonate. |
title_fullStr |
Clinical significance of plasma N-terminal pro- B-type natriuretic peptide in respiratory distress syndrome of the preterm neonate. |
title_full_unstemmed |
Clinical significance of plasma N-terminal pro- B-type natriuretic peptide in respiratory distress syndrome of the preterm neonate. |
title_sort |
Clinical significance of plasma N-terminal pro- B-type natriuretic peptide in respiratory distress syndrome of the preterm neonate. |
author |
Rocha, Gustavo |
author_facet |
Rocha, Gustavo Clemente, Fátima Rodrigues, Teresa Guimarães, Hercília |
author_role |
author |
author2 |
Clemente, Fátima Rodrigues, Teresa Guimarães, Hercília |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Rocha, Gustavo Clemente, Fátima Rodrigues, Teresa Guimarães, Hercília |
description |
Plasma brain-type natriuretic peptide (BNP) is secreted by cardiac myocytes in response to pressure or volume overload. Recently, an assay to measure the N-terminal segment of the pro-hormone (NT-pro-BNP) was developed.(1) To determine the plasma levels of NT-pro-BNP in premature neonates without congenital heart disease; (2) to determine the relationship between the severity of respiratory distress syndrome (RDS) and plasma levels of NT-pro-BNP.Plasma levels of NT-pro-BNP were measured in premature neonates ( |
publishDate |
2009 |
dc.date.none.fl_str_mv |
2009-08-30 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1707 oai:ojs.www.actamedicaportuguesa.com:article/1707 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1707 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/1707 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1707 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1707/1286 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 22 No. 4 (2009): Julho-Agosto; 349-54 Acta Médica Portuguesa; Vol. 22 N.º 4 (2009): Julho-Agosto; 349-54 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130626285109248 |